NUSConsumer Defensive · Household & Personal ProductsTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 66 of 100 as at 22 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Nu Skin Enterprises, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Momentum (16): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on NUS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 20 Dec 2024 | DA Davidson | Maintains | Neutral | $11 → $7.00 |
| 22 Oct 2024 | Citigroup | Maintains | Neutral | — |
| 12 Aug 2024 | DA Davidson | Maintains | Neutral | — |
| 9 Aug 2024 | Citigroup | Maintains | Neutral | — |
| 9 May 2024 | DA Davidson | Maintains | Neutral | — |
| 5 Jan 2024 | DA Davidson | Maintains | Neutral | — |
| 16 Oct 2023 | Stifel | Maintains | Hold | — |
| 29 Sept 2023 | Citigroup | Maintains | Neutral | — |
| 3 Aug 2023 | DA Davidson | Reiterates | Neutral | — |
| 2 Aug 2023 | Stifel | Maintains | Hold | — |
| 19 May 2023 | DA Davidson | Reiterates | Neutral | — |
| 1 Mar 2023 | Citigroup | Maintains | Neutral | — |
| 16 Feb 2023 | DA Davidson | Maintains | Neutral | — |
| 31 Jan 2023 | Jefferies | Downgrade | Hold | — |
| 23 Nov 2022 | DA Davidson | Maintains | Neutral | — |
| 5 Oct 2022 | Citigroup | Maintains | Neutral | — |
| 23 Aug 2022 | DA Davidson | Maintains | Neutral | — |
| 8 Aug 2022 | Citigroup | Maintains | Neutral | — |
| 5 May 2022 | DA Davidson | Maintains | Neutral | — |
| 17 Feb 2022 | DA Davidson | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NUS appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 66% of US stocks
Cheaper than 94% of US stocks
Cheaper than 89% of US stocks
Cheaper than 56% of US stocks
Higher than 12% of US stocks
Higher than 24% of US stocks
Higher than 80% of US stocks
Higher than 57% of US stocks
Higher than 17% of US stocks
Higher than 26% of US stocks
Higher than 68% of US stocks
Higher than 83% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Nu Skin Enterprises, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Stonegate Capital Partners updated its coverage on NU Skin Enterprises Inc. after the company reported revenue of $320.1 million, adjusted net income of $10.0 million, and adjusted EPS of $0.20 for 2Q26.
Why it matters — The update provides NUS watchers with fresh analyst attention and reported financial figures for the second quarter of 2026.
Nu Skin Enterprises reported second-quarter results that met analyst estimates, though revenues fell 17.1% year-over-year and EPS declined 53.5%. The company also lowered its 2026 revenue and adjusted EPS outlooks.
Why it matters — Nu Skin watchers would care because the steep year-over-year revenue and earnings declines, along with the reduced 2026 guidance, signal sustained pressure on the company's performance and future expectations.
Nu Skin Enterprises, Inc. published its Q2 2026 earnings call transcript on Seeking Alpha, covering the company's second-quarter results and management commentary.
Why it matters — Investors following Nu Skin can review management's discussion of the company's latest quarterly performance directly from the call.
Nu Skin Enterprises reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, while continuing the rollout of its Prysm iO wellness platform and pursuing cost and margin initiatives.
Why it matters — The report provides an update on Nu Skin's recent financial performance and the progress of its strategic wellness-platform rollout and margin efforts, which matter to shareholders tracking the company's execution.
Nu Skin Enterprises reported quarterly earnings of $0.20 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.43 per share in the same quarter a year ago.
Why it matters — NUS watchers would care because the results show earnings matched analyst expectations while declining significantly year over year.
As at 22 Aug 2026, Nu Skin Enterprises, Inc. ranks 66 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).
No analyst covering Nu Skin Enterprises, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $13 over the next 12 months.
Nu Skin Enterprises, Inc. returned -57.2% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Nu Skin Enterprises Inc. is a global direct selling company specializing in the marketing and distribution of premium-quality personal care products and dietary supplements.
The most recent item we track (Newsfile Corp, 11 Aug 2026): "Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26". Stonegate Capital Partners updated its coverage on NU Skin Enterprises Inc. after the company reported revenue of $320.1 million, adjusted net income of $10.0 million, and adjusted EPS of $0.20 for 2Q26.
Nu Skin Enterprises Inc. is a global direct selling company specializing in the marketing and distribution of premium-quality personal care products and dietary supplements. The company's primary purpose is to empower individuals by providing them with the opportunity to run personal businesses by selling its diverse array of beauty and wellness products. Notably, it operates in sectors like skincare, health and nutrition, aiming to promote healthier lifestyles and aging solutions. Nu Skin leverages a unique business model, combining innovative product development with a robust, entrepreneur-focused sales strategy. This model not only impacts individuals at the grassroots level by fostering entrepreneurial initiatives but also significantly influences the larger market trends in nutraceuticals and personal care. Established in 1984 and headquartered in Provo, Utah, Nu Skin has expanded its reach globally, with operations in multiple international markets. It is recognized for its commitment to quality and sustainability, integrating cutting-edge scientific research into its product offerings while maintaining a strong presence in the competitive direct selling industry.
CEO Mr. Ryan S. Napierski · 2,800 employees · United States · https://www.nuskin.com